Immunome Inc (IMNM) USD0.0001

Sell:$16.77Buy:$18.00$1.23 (6.71%)

Prices delayed by at least 15 minutes
Sell:$16.77
Buy:$18.00
Change:$1.23 (6.71%)
Prices delayed by at least 15 minutes
Sell:$16.77
Buy:$18.00
Change:$1.23 (6.71%)
Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
3 June 2025
Jean Jacques BienaimeIndependent Director
Buy
Regular purchase transaction
5,000$9.38$46,900.0036,415
26 March 2025
Clay B SiegallChairman/CEO
Buy
Regular purchase transaction
137,100$7.29$999,459.00806,736
25 March 2025
Jean Jacques BienaimeIndependent Director
Buy
Regular purchase transaction
7,800$7.78$60,684.0031,415
24 March 2025
Philip TsaiCTO
Buy
Regular purchase transaction
12,300$8.42$103,566.0033,300
24 March 2025
Jean Jacques BienaimeIndependent Director
Buy
Regular purchase transaction
7,000$8.21$57,470.0023,615
31 January 2025
Clay B SiegallChairman/CEO
Buy
Regular purchase transaction
150,000$7.75$1,162,500.00669,636

End of results. Director deals are only available for the last 12 months.

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
31 January 2025
Clay B SiegallChairman/CEO
Buy
Regular purchase transaction
150,000$7.75$1,162,500.00669,636
26 March 2025
Clay B SiegallChairman/CEO
Buy
Regular purchase transaction
137,100$7.29$999,459.00806,736
24 March 2025
Philip TsaiCTO
Buy
Regular purchase transaction
12,300$8.42$103,566.0033,300
25 March 2025
Jean Jacques BienaimeIndependent Director
Buy
Regular purchase transaction
7,800$7.78$60,684.0031,415
24 March 2025
Jean Jacques BienaimeIndependent Director
Buy
Regular purchase transaction
7,000$8.21$57,470.0023,615

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.